These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9145815)

  • 1. Sequential antimicrobial therapy--the role of quinolones.
    Nathwani D; Tillotson G; Davey P
    J Antimicrob Chemother; 1997 Apr; 39(4):441-6. PubMed ID: 9145815
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential antimicrobial therapy: a realistic approach to cost containment?
    Guay DR
    Pharmacoeconomics; 1993 May; 3(5):341-4. PubMed ID: 10146884
    [No Abstract]   [Full Text] [Related]  

  • 3. Grepafloxacin--a new fluoroquinolone.
    Med Lett Drugs Ther; 1998 Jan; 40(1019):17-8. PubMed ID: 9465856
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
    Shorr AF; Susla GB; Kollef MH
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S115-22. PubMed ID: 15712099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
    Vogel F; Lode H
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():81-6. PubMed ID: 1664833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic evaluation of enrofloxacin in chickens.
    Abd el-Aziz MI; Aziz MA; Soliman FA; Afify NA
    Br Poult Sci; 1997 May; 38(2):164-8. PubMed ID: 9158891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sparfloxacin and levofloxacin.
    Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295
    [No Abstract]   [Full Text] [Related]  

  • 8. A pharmacist-initiated program of intravenous to oral antibiotic conversion.
    Przybylski KG; Rybak MJ; Martin PR; Weingarten CM; Zaran FK; Stevenson JG; Levine DP
    Pharmacotherapy; 1997; 17(2):271-6. PubMed ID: 9085318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Difluoroquinolone lomefloxacin (Maxaquin): its role among fluoroquinolones, possibilities and prospectives].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(10):4-9. PubMed ID: 9825101
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis in transurethral surgery: oral lomefloxacin versus intravenous cefuroxime.
    Martín-Luengo F; Fontana L; Rico JL; Tomás-Ros M; Murcia A; Romero A
    Methods Find Exp Clin Pharmacol; 1993; 15(1):57-9. PubMed ID: 8386794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of enrofloxacin in the treatment of respiratory pasteurellosis in rabbits.
    Broome RL; Brooks DL
    Lab Anim Sci; 1991 Dec; 41(6):572-6. PubMed ID: 1667200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
    Norrby SR
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():99-101. PubMed ID: 9484879
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost effectiveness of quinolones in hospitals and the community.
    Davey P
    Drugs; 1999; 58 Suppl 2():71-7. PubMed ID: 10553710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia].
    Padeĭskaia EN
    Antibiot Khimioter; 2000; 45(1):39-44. PubMed ID: 10690427
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinolones: clinical use and formulary considerations.
    Cunha BA
    Adv Ther; 1998; 15(5):277-87. PubMed ID: 10345149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?
    Vogel F
    Drugs; 2002; 62(2):309-17. PubMed ID: 11817975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosoxacin in the treatment of uncomplicated acute gonococcal urethritis.
    Vagaskar SR; Fernandez RJ; Wagle UD; Rajani ND
    J Postgrad Med; 1990 Oct; 36(4):191-3. PubMed ID: 1966732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.